diclofenac has been researched along with Central Retinal Edema, Cystoid in 36 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients preoperatively treated with diclofenac had significantly lower intraocular levels of IL-12 and a lower increase in CFT, which indicates that a combination of preoperative and postoperative treatment with a topical NSAID may lower the incidence of postoperative macular edema in patients with diabetic retinopathy." | 9.24 | Effect of preoperative topical diclofenac on intraocular interleukin-12 concentration and macular edema after cataract surgery in patients with diabetic retinopathy: a randomized controlled trial. ( Jukić, T; Matas, A; Medić, A; Sapunar, A; Vukojević, K; Znaor, L, 2017) |
| "The purpose of the study is to compare single injection of intravitreal diclofenac (IVD) with intravitreal bevacizumab (IVB) in the treatment of eyes with naïve diabetic macular edema (DME)." | 9.20 | Intravitreal diclofenac versus intravitreal bevacizumab in naive diabetic macular edema: a randomized double-masked clinical trial. ( Karimi, S; Montahai, T; Peyman, GA; Ramezani, A; Soheilian, M; Soheilian, R; Yaseri, M, 2015) |
| "To compare the effect of intravitreal diclofenac (IVD) versus intravitreal triamcinolone (IVT) on refractory uveitic cystoid macular edema (CME)." | 9.17 | A pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edema. ( Eskandari, A; Rabbanikhah, Z; Ramezani, A; Soheilian, M; Soheilian, R, 2013) |
| "To compare the efficacy and safety of intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema." | 9.15 | Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema. ( Elbendary, AM; Shahin, MM, 2011) |
| "The purpose of this study was to evaluate the effect of a single dose of intravitreal diclofenac, a potent nonsteroidal antiinflammatory drug, on visual acuity and central macular thickness in patients with macular edema of various etiologies." | 9.14 | Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies. ( Karimi, S; Peyman, GA; Ramezani, A; Soheilian, M, 2010) |
| "This study compares the effect of topical diclofenac with that of betamethasone against postoperative cystoid macular edema (CME) following cataract surgery in patients with non- and mild nonproliferative diabetic retinopathy." | 9.12 | Diclofenac prevents an early event of macular thickening after cataract surgery in patients with diabetes. ( Nakazawa, T; Nishida, K; Shimura, M; Yasuda, K, 2007) |
| " Because administration of nonsteroidal eyedrops such as diclofenac seems to prevent the adverse effects of latanoprost therapy while maintaining its effect to lower intraocular pressure, we suggest their concurrent application." | 9.09 | Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. ( Ichihashi, S; Maekubo, K; Miyake, K; Miyake, S; Ota, I, 1999) |
| " The concurrent administration of nonsteroidal anti-inflammatory drug such as diclofenac prevents these adverse effects without interfering with the drop in intraocular pressure caused by timolol." | 9.09 | Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia. ( Akura, J; Ibaraki, N; Ichihashi, S; Maekubo, K; Miyake, K; Miyake, S; Ota, I; Shibuya, Y, 2001) |
| "To evaluate the effectiveness of diclofenac eyedrops in reducing inflammation and the incidence of angiographic cystoid macular edema (CME) after cataract surgery and intraocular lens (IOL) implantation." | 9.08 | Effectiveness of diclofenac eyedrops in reducing inflammation and the incidence of cystoid macular edema after cataract surgery. ( Bujtar, E; Castoldi, D; Orzalesi, N; Rossetti, L; Torrazza, C, 1996) |
| "Diclofenac sodium was as effective as the control regimen in controlling postoperative inflammation after cataract surgery." | 9.08 | Efficacy of diclofenac eyedrops in preventing postoperative inflammation and long-term cystoid macular edema. Italian Diclofenac Study Group. ( , 1997) |
| "1% fluorometholone) in preventing cystoid macular edema (CME) and inducing disruption of the blood-aqueous barrier determined by laser flare cellmetry." | 9.08 | [Preventive effects of diclofenac ophthalmic solution on post-cataract-surgical cystoid macular edema]. ( Eguchi, K; Hayashi, F; Hoshi, H; Kimura, W; Majima, Y; Masuda, K; Miyake, K; Oshika, T; Shirato, S, 1998) |
| "Intravitreal diclofenac (IVD) may be a promising treatment for refractory uveitis-associated CME." | 7.88 | Intravitreal diclofenac for treatment of refractory uveitis-associated cystoid macular oedema: A before and after clinical study. ( Kianersi, F; Kianersi, H; Pourazizi, M; Rezaeian-Ramsheh, A, 2018) |
| "1 mL of intravitreal diclofenac under aseptic conditions and followed up for 3 months with respect to best-corrected visual acuity (BCVA), intraocular pressure (IOP), fundus fluorescein angiography, and CMT measured on OCT." | 7.83 | Intravitreal Diclofenac in the Treatment of Macular Edema Due to Branch Retinal Vein Occlusion. ( Arora, S; Ghosh, B; Gupta, A; Raina, UK; Seth, A, 2016) |
| "Diclofenac was more effective than betamethasone in preventing angiographic CME and BAB disruption after small-incision cataract surgery." | 6.73 | Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethason ( Asano, S; Kimura, W; Miyake, K; Ota, I; Sakka, Y; Sugita, G; Yabe, N, 2008) |
| "The addition of diclofenac or bromfenac ophthalmic solutions contributed to further reduce both inflammation and cystoid macular edema after cataract surgery compared to steroid-antibiotic combination alone." | 5.27 | The Comparative Efficacy and Tolerability of Diclofenac 0.1% and Bromfenac 0.09% Ophthalmic Solutions after Cataract Surgery. ( Campos, EC; Finzi, A; Giannaccare, G; Greco, F; Sebastiani, S; Versura, P, 2018) |
| "Patients preoperatively treated with diclofenac had significantly lower intraocular levels of IL-12 and a lower increase in CFT, which indicates that a combination of preoperative and postoperative treatment with a topical NSAID may lower the incidence of postoperative macular edema in patients with diabetic retinopathy." | 5.24 | Effect of preoperative topical diclofenac on intraocular interleukin-12 concentration and macular edema after cataract surgery in patients with diabetic retinopathy: a randomized controlled trial. ( Jukić, T; Matas, A; Medić, A; Sapunar, A; Vukojević, K; Znaor, L, 2017) |
| "The purpose of the study is to compare single injection of intravitreal diclofenac (IVD) with intravitreal bevacizumab (IVB) in the treatment of eyes with naïve diabetic macular edema (DME)." | 5.20 | Intravitreal diclofenac versus intravitreal bevacizumab in naive diabetic macular edema: a randomized double-masked clinical trial. ( Karimi, S; Montahai, T; Peyman, GA; Ramezani, A; Soheilian, M; Soheilian, R; Yaseri, M, 2015) |
| "To compare the effect of intravitreal diclofenac (IVD) versus intravitreal triamcinolone (IVT) on refractory uveitic cystoid macular edema (CME)." | 5.17 | A pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edema. ( Eskandari, A; Rabbanikhah, Z; Ramezani, A; Soheilian, M; Soheilian, R, 2013) |
| "To compare the efficacy and safety of intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema." | 5.15 | Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema. ( Elbendary, AM; Shahin, MM, 2011) |
| "The purpose of this study was to evaluate the effect of a single dose of intravitreal diclofenac, a potent nonsteroidal antiinflammatory drug, on visual acuity and central macular thickness in patients with macular edema of various etiologies." | 5.14 | Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies. ( Karimi, S; Peyman, GA; Ramezani, A; Soheilian, M, 2010) |
| "Although NSAID therapy seems to potentiate the improvements produced by corticosteroids and antivascular endothelial growth factor therapy for chronic pseudophakic cystoid macular edema, only nepafenac- and bromfenac-treated eyes showed reduced retinal thickness at 12 weeks and 16 weeks." | 5.14 | NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema. ( Bahrani, H; Fox, JE; Warren, KA, 2010) |
| "This study compares the effect of topical diclofenac with that of betamethasone against postoperative cystoid macular edema (CME) following cataract surgery in patients with non- and mild nonproliferative diabetic retinopathy." | 5.12 | Diclofenac prevents an early event of macular thickening after cataract surgery in patients with diabetes. ( Nakazawa, T; Nishida, K; Shimura, M; Yasuda, K, 2007) |
| " Because administration of nonsteroidal eyedrops such as diclofenac seems to prevent the adverse effects of latanoprost therapy while maintaining its effect to lower intraocular pressure, we suggest their concurrent application." | 5.09 | Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. ( Ichihashi, S; Maekubo, K; Miyake, K; Miyake, S; Ota, I, 1999) |
| " The concurrent administration of nonsteroidal anti-inflammatory drug such as diclofenac prevents these adverse effects without interfering with the drop in intraocular pressure caused by timolol." | 5.09 | Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia. ( Akura, J; Ibaraki, N; Ichihashi, S; Maekubo, K; Miyake, K; Miyake, S; Ota, I; Shibuya, Y, 2001) |
| "To evaluate the effectiveness of diclofenac eyedrops in reducing inflammation and the incidence of angiographic cystoid macular edema (CME) after cataract surgery and intraocular lens (IOL) implantation." | 5.08 | Effectiveness of diclofenac eyedrops in reducing inflammation and the incidence of cystoid macular edema after cataract surgery. ( Bujtar, E; Castoldi, D; Orzalesi, N; Rossetti, L; Torrazza, C, 1996) |
| "Diclofenac sodium was as effective as the control regimen in controlling postoperative inflammation after cataract surgery." | 5.08 | Efficacy of diclofenac eyedrops in preventing postoperative inflammation and long-term cystoid macular edema. Italian Diclofenac Study Group. ( , 1997) |
| "1% fluorometholone) in preventing cystoid macular edema (CME) and inducing disruption of the blood-aqueous barrier determined by laser flare cellmetry." | 5.08 | [Preventive effects of diclofenac ophthalmic solution on post-cataract-surgical cystoid macular edema]. ( Eguchi, K; Hayashi, F; Hoshi, H; Kimura, W; Majima, Y; Masuda, K; Miyake, K; Oshika, T; Shirato, S, 1998) |
| "Intravitreal diclofenac (IVD) may be a promising treatment for refractory uveitis-associated CME." | 3.88 | Intravitreal diclofenac for treatment of refractory uveitis-associated cystoid macular oedema: A before and after clinical study. ( Kianersi, F; Kianersi, H; Pourazizi, M; Rezaeian-Ramsheh, A, 2018) |
| "1 mL of intravitreal diclofenac under aseptic conditions and followed up for 3 months with respect to best-corrected visual acuity (BCVA), intraocular pressure (IOP), fundus fluorescein angiography, and CMT measured on OCT." | 3.83 | Intravitreal Diclofenac in the Treatment of Macular Edema Due to Branch Retinal Vein Occlusion. ( Arora, S; Ghosh, B; Gupta, A; Raina, UK; Seth, A, 2016) |
| "Diclofenac was the most likely to reduce the odds of developing CME compared with bromfenac and nepafenac." | 3.01 | Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs and corticosteroid drugs for prevention of cystoid macular edema after cataract surgery. ( Chen, X; Li, SS; Wang, HH; Wang, YL; Zhang, DW, 2023) |
| "Diclofenac was more effective than betamethasone in preventing angiographic CME and BAB disruption after small-incision cataract surgery." | 2.73 | Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethason ( Asano, S; Kimura, W; Miyake, K; Ota, I; Sakka, Y; Sugita, G; Yabe, N, 2008) |
| "Initial angiographic cystoid macular edema was comparable and significantly improved after therapy in the two treatment groups." | 2.67 | [Differential treatment of postoperative and uveitis-induced inflammatory cystoid macular edema]. ( Guex-Crosier, Y; Herbort, CP; Othenin-Girard, P, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (5.56) | 18.7374 |
| 1990's | 6 (16.67) | 18.2507 |
| 2000's | 5 (13.89) | 29.6817 |
| 2010's | 21 (58.33) | 24.3611 |
| 2020's | 2 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Li, SS | 1 |
| Wang, HH | 1 |
| Wang, YL | 1 |
| Zhang, DW | 1 |
| Chen, X | 1 |
| Wingert, AM | 2 |
| Liu, SH | 2 |
| Lin, JC | 2 |
| Sridhar, J | 2 |
| Ylinen, P | 2 |
| Holmström, E | 2 |
| Laine, I | 2 |
| Lindholm, JM | 2 |
| Tuuminen, R | 2 |
| Kianersi, F | 2 |
| Rezaeian-Ramsheh, A | 1 |
| Pourazizi, M | 1 |
| Kianersi, H | 1 |
| Giannaccare, G | 1 |
| Finzi, A | 1 |
| Sebastiani, S | 1 |
| Greco, F | 1 |
| Versura, P | 1 |
| Campos, EC | 1 |
| Taipale, C | 1 |
| Soheilian, M | 3 |
| Eskandari, A | 1 |
| Ramezani, A | 4 |
| Rabbanikhah, Z | 1 |
| Soheilian, R | 2 |
| Jin Choi, H | 1 |
| Moyer, K | 1 |
| DeWilde, A | 1 |
| Law, C | 1 |
| Karimi, S | 2 |
| Montahai, T | 1 |
| Yaseri, M | 2 |
| Peyman, GA | 2 |
| Gaskin, JC | 1 |
| Coote, M | 1 |
| Lee, TH | 1 |
| Choi, W | 1 |
| Ji, YS | 1 |
| Yoon, KC | 1 |
| Shorstein, NH | 1 |
| Liu, L | 1 |
| Waxman, MD | 1 |
| Herrinton, LJ | 1 |
| Seth, A | 1 |
| Ghosh, B | 1 |
| Raina, UK | 1 |
| Gupta, A | 1 |
| Arora, S | 1 |
| Entezari, M | 1 |
| Nikkhah, H | 1 |
| Ghanbari, H | 1 |
| Sonbolestan, SA | 1 |
| Abtahi, MA | 1 |
| Akbari, M | 1 |
| Abtahi, ZA | 1 |
| Abtahi, SH | 1 |
| Medić, A | 1 |
| Jukić, T | 1 |
| Matas, A | 1 |
| Vukojević, K | 1 |
| Sapunar, A | 1 |
| Znaor, L | 1 |
| Warren, KA | 1 |
| Bahrani, H | 1 |
| Fox, JE | 1 |
| Elbendary, AM | 1 |
| Shahin, MM | 1 |
| Romac, I | 1 |
| Gabrić, N | 1 |
| Dekaris, I | 1 |
| Barisić, A | 1 |
| Gallego-Pinazo, R | 1 |
| Martínez Castillo, S | 1 |
| Dolz-Marco, R | 1 |
| Lleó-Pérez, A | 1 |
| Díaz-Llopis, M | 1 |
| Kim, SJ | 1 |
| Rho, DS | 1 |
| Shimura, M | 1 |
| Nakazawa, T | 1 |
| Yasuda, K | 1 |
| Nishida, K | 1 |
| Miyake, K | 6 |
| Nishimura, K | 1 |
| Harino, S | 1 |
| Ota, I | 4 |
| Asano, S | 2 |
| Kondo, N | 1 |
| Miyake, S | 3 |
| Sugita, G | 1 |
| Kimura, W | 2 |
| Sakka, Y | 1 |
| Yabe, N | 1 |
| Gills, JP | 1 |
| Rossetti, L | 1 |
| Bujtar, E | 1 |
| Castoldi, D | 1 |
| Torrazza, C | 1 |
| Orzalesi, N | 1 |
| Masuda, K | 2 |
| Shirato, S | 1 |
| Oshika, T | 1 |
| Eguchi, K | 1 |
| Hoshi, H | 1 |
| Majima, Y | 1 |
| Hayashi, F | 1 |
| Maekubo, K | 2 |
| Ichihashi, S | 2 |
| Ibaraki, N | 1 |
| Akura, J | 1 |
| Shibuya, Y | 1 |
| Guex-Crosier, Y | 1 |
| Othenin-Girard, P | 1 |
| Herbort, CP | 1 |
| Mishima, H | 1 |
| Quentin, CD | 1 |
| Behrens-Baumann, W | 1 |
| Gaus, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluating the Efficacy, Compliance, and Patient Satisfaction of a New Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population[NCT05157113] | Phase 4 | 70 participants (Anticipated) | Interventional | 2022-05-31 | Recruiting | ||
| A Randomised Control Study to Investigate if the Continuation of Prostaglandin Analogue Treatments in the Post-operative Phase of Glaucoma Patients Undergoing Cataract Surgery Increases the Incidence of Cystoid Macular Oedema.[NCT03292796] | Phase 2 | 56 participants (Actual) | Interventional | 2016-12-07 | Completed | ||
| Evaluation of Macular Thickness in Patients With Glaucoma in Use of Topical Prostaglandin Analogue Undergoing Trabeculectomy With Mitomycin C[NCT06000280] | 37 participants (Actual) | Interventional | 2021-01-04 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for diclofenac and Central Retinal Edema, Cystoid
| Article | Year |
|---|---|
Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs and corticosteroid drugs for prevention of cystoid macular edema after cataract surgery.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Cataract; Cataract | 2023 |
Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cataract; Diclofenac; Female; Humans; Ketorolac; Macu | 2022 |
Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cataract; Diclofenac; Female; Humans; Ketorolac; Macu | 2022 |
Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cataract; Diclofenac; Female; Humans; Ketorolac; Macu | 2022 |
Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cataract; Diclofenac; Female; Humans; Ketorolac; Macu | 2022 |
The putative role of prostaglandins in cystoid macular edema.
Topics: Aqueous Humor; Cataract Extraction; Diclofenac; Fluorescein Angiography; Flurbiprofen; Humans; Indom | 1989 |
20 trials available for diclofenac and Central Retinal Edema, Cystoid
| Article | Year |
|---|---|
The Comparative Efficacy and Tolerability of Diclofenac 0.1% and Bromfenac 0.09% Ophthalmic Solutions after Cataract Surgery.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cata | 2018 |
A pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edema.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Follow-Up Stud | 2013 |
Intravitreal diclofenac versus intravitreal bevacizumab in naive diabetic macular edema: a randomized double-masked clinical trial.
Topics: Adult; Aged; Analysis of Variance; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; | 2015 |
The effect of topical sodium diclofenac on macular thickness in diabetic eyes after phacoemulsification: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diabetic Retinopathy; Diclofenac; | 2017 |
Intravitreal Diclofenac plus Bevacizumab versus Bevacizumab alone in treatment-naive diabetic macular edema: a randomized double-blind clinical trial.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Bevacizumab; Diabetic Retinopathy; | 2017 |
Effect of preoperative topical diclofenac on intraocular interleukin-12 concentration and macular edema after cataract surgery in patients with diabetic retinopathy: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antibiotic Prophylaxis; Aqueous Hu | 2017 |
Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Electroretinography; F | 2010 |
NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antibodie | 2010 |
Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diabetic Retinopathy; Diclofenac; Female; Glucocorti | 2011 |
Treatment of acute pseudophakic cystoid macular edema: Diclofenac versus ketorolac.
Topics: Administration, Topical; Aged; Cyclooxygenase Inhibitors; Diclofenac; Drug Evaluation; Female; Human | 2003 |
Diclofenac prevents an early event of macular thickening after cataract surgery in patients with diabetes.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents | 2007 |
The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Flow Velocity; Blood-A | 2007 |
Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethason
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Blood-Aqueous | 2008 |
Effectiveness of diclofenac eyedrops in reducing inflammation and the incidence of cystoid macular edema after cataract surgery.
Topics: Administration, Topical; Aged; Anterior Chamber; Anti-Inflammatory Agents, Non-Steroidal; Cataract E | 1996 |
Efficacy of diclofenac eyedrops in preventing postoperative inflammation and long-term cystoid macular edema. Italian Diclofenac Study Group.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cataract Extraction; Diclofenac; Double-Blind Method; | 1997 |
[Preventive effects of diclofenac ophthalmic solution on post-cataract-surgical cystoid macular edema].
Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Blood-Aqueous Barrier; Cata | 1998 |
Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias.
Topics: Aged; Blood-Aqueous Barrier; Cataract Extraction; Diclofenac; Double-Blind Method; Female; Fluoresce | 1999 |
Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Aged; Anterior Eye Segment; Anti-Inflammatory | 2001 |
[Differential treatment of postoperative and uveitis-induced inflammatory cystoid macular edema].
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Diclofenac; Female; Humans; Injections; Lenses, Intra | 1992 |
[Prevention of cystoid macular edema with diclofenac eyedrops in intracapsular cataract extraction using the Choyce Mark IX anterior chamber lens].
Topics: Aged; Diclofenac; Double-Blind Method; Female; Humans; Lenses, Intraocular; Macular Edema; Male; Oph | 1989 |
13 other studies available for diclofenac and Central Retinal Edema, Cystoid
| Article | Year |
|---|---|
Anti-inflammatory medication following cataract surgery: a randomized trial between preservative-free dexamethasone, diclofenac and their combination.
Topics: Aged; Anti-Inflammatory Agents; Cataract Extraction; Dexamethasone; Diclofenac; Dose-Response Relati | 2018 |
Intravitreal diclofenac for treatment of refractory uveitis-associated cystoid macular oedema: A before and after clinical study.
Topics: Adolescent; Adult; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Fluoresc | 2018 |
Postoperative management in cataract surgery: nepafenac and preservative-free diclofenac compared.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneac | 2018 |
Corneal edema and cystoid macular edema by nuclear fragments after uneventful phacoemulsification.
Topics: Acetazolamide; Aged; Anterior Eye Segment; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-S | 2013 |
Cystoid macular edema from cancer-associated retinopathy.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Therapy, Combination; Fluorescein An | 2014 |
Postoperative cystoid macular oedema in a patient on fingolimod.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cataract Extraction; Diclofenac; Female; Fingolimod Hydroch | 2015 |
Comparison of ketorolac 0.45% versus diclofenac 0.1% for macular thickness and volume after uncomplicated cataract surgery.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Humans; Intrao | 2016 |
Comparative Effectiveness of Three Prophylactic Strategies to Prevent Clinical Macular Edema after Phacoemulsification Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diclofena | 2015 |
Intravitreal Diclofenac in the Treatment of Macular Edema Due to Branch Retinal Vein Occlusion.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Fluorescein Angiography; F | 2016 |
Resolution of pseudophakic cystoid macular edema with combination therapy of topical corticosteroids and nonsteroidal anti-inflammatory drugs.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Dexamethasone; Diclofenac; Drug Therapy, Combination; | 2011 |
[Analysis of prognostic factors by spectral-domain optical coherence tomography in pseudophakic cystoid macular oedema].
Topics: Acetazolamide; Aged; Anti-Inflammatory Agents; Diclofenac; Female; Humans; Macular Edema; Male; Post | 2012 |
“Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema”.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diabetic Retinopathy; Diclofenac; Female; Glucocorticoids; | 2012 |
Voltaren associated with medication keratitis.
Topics: Diclofenac; Drug Hypersensitivity; Humans; Keratitis; Macular Edema | 1994 |